Virtual Reality for Sedation During Atrial Fibrillation Ablation in Clinical Practice: Observational Study.
atrial fibrillation
connected devices
pain management
virtual reality
Journal
Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882
Informations de publication
Date de publication:
27 05 2021
27 05 2021
Historique:
received:
08
12
2020
accepted:
04
05
2021
revised:
23
03
2021
entrez:
27
5
2021
pubmed:
28
5
2021
medline:
2
10
2021
Statut:
epublish
Résumé
Connected devices are dramatically changing many aspects in health care. One such device, the virtual reality (VR) headset, has recently been shown to improve analgesia in a small sample of patients undergoing transcatheter aortic valve implantation. We aimed to investigate the feasibility and effectiveness of VR in patients undergoing atrial fibrillation (AF) ablation under conscious sedation. All patients who underwent an AF ablation with VR from March to May 2020 were included. Patients were compared to a consecutive cohort of patients who underwent AF ablation in the 3 months prior to the study. Primary efficacy was assessed by using a visual analog scale, summarizing the overall pain experienced during the ablation. The AF cryoablation procedure with VR was performed for 48 patients (mean age 63.0, SD 10.9 years; n=16, 33.3% females). No patient refused to use the device, although 14.6% (n=7) terminated the VR session prematurely. Preparation of the VR headset took on average 78 (SD 13) seconds. Compared to the control group, the mean perceived pain, assessed with the visual analog scale, was lower in the VR group (3.5 [SD 1.5] vs 4.3 [SD 1.6]; P=.004), and comfort was higher in the VR group (7.5 [SD 1.6] vs 6.8 [SD 1.7]; P=.03). On the other hand, morphine consumption was not different between the groups. Lastly, complications, as well as procedure and fluoroscopy duration, were not different between the two groups. We found that VR was associated with a reduction in the perception of pain in patients undergoing AF ablation under conscious sedation. Our findings demonstrate that VR can be easily incorporated into the standard ablation workflow.
Sections du résumé
BACKGROUND
Connected devices are dramatically changing many aspects in health care. One such device, the virtual reality (VR) headset, has recently been shown to improve analgesia in a small sample of patients undergoing transcatheter aortic valve implantation.
OBJECTIVE
We aimed to investigate the feasibility and effectiveness of VR in patients undergoing atrial fibrillation (AF) ablation under conscious sedation.
METHODS
All patients who underwent an AF ablation with VR from March to May 2020 were included. Patients were compared to a consecutive cohort of patients who underwent AF ablation in the 3 months prior to the study. Primary efficacy was assessed by using a visual analog scale, summarizing the overall pain experienced during the ablation.
RESULTS
The AF cryoablation procedure with VR was performed for 48 patients (mean age 63.0, SD 10.9 years; n=16, 33.3% females). No patient refused to use the device, although 14.6% (n=7) terminated the VR session prematurely. Preparation of the VR headset took on average 78 (SD 13) seconds. Compared to the control group, the mean perceived pain, assessed with the visual analog scale, was lower in the VR group (3.5 [SD 1.5] vs 4.3 [SD 1.6]; P=.004), and comfort was higher in the VR group (7.5 [SD 1.6] vs 6.8 [SD 1.7]; P=.03). On the other hand, morphine consumption was not different between the groups. Lastly, complications, as well as procedure and fluoroscopy duration, were not different between the two groups.
CONCLUSIONS
We found that VR was associated with a reduction in the perception of pain in patients undergoing AF ablation under conscious sedation. Our findings demonstrate that VR can be easily incorporated into the standard ablation workflow.
Identifiants
pubmed: 34042589
pii: v23i5e26349
doi: 10.2196/26349
pmc: PMC8193475
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e26349Informations de copyright
©Thomas Roxburgh, Anthony Li, Charles Guenancia, Patrice Pernollet, Claire Bouleti, Benjamin Alos, Matthieu Gras, Thomas Kerforne, Denis Frasca, François Le Gal, Luc Christiaens, Bruno Degand, Rodrigue Garcia. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 27.05.2021.
Références
Neuron. 2017 Feb 22;93(4):723-724
pubmed: 28231458
Sci Rep. 2020 Jun 3;10(1):9067
pubmed: 32494060
J Med Internet Res. 2020 Nov 2;22(11):e17980
pubmed: 33136055
PLoS One. 2019 Aug 14;14(8):e0219115
pubmed: 31412029
Pain Manag. 2018 May;8(3):175-179
pubmed: 29722606
JMIR Ment Health. 2017 Mar 29;4(1):e9
pubmed: 28356241
J Med Internet Res. 2020 Dec 1;22(12):e19150
pubmed: 33258776
Einstein (Sao Paulo). 2019 May 20;17(2):eMD4837
pubmed: 31116237
Eur J Neurosci. 2019 Nov;50(10):3557-3565
pubmed: 31233640
EuroIntervention. 2020 Dec 18;16(12):e1014-e1020
pubmed: 32597390
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
World Neurosurg. 2020 Feb;134:e937-e943
pubmed: 31734424
Front Psychol. 2013 Sep 09;4:607
pubmed: 24058354
Am J Transl Res. 2020 Sep 15;12(9):5818-5826
pubmed: 33042461
Europace. 2021 Apr 6;23(4):557-564
pubmed: 33221901
J Med Internet Res. 2020 Apr 28;22(4):e14201
pubmed: 32343254
JACC Clin Electrophysiol. 2020 Nov;6(12):1551-1560
pubmed: 33213815
J Med Internet Res. 2020 Dec 1;22(12):e24087
pubmed: 33147166
J Med Internet Res. 2020 May 21;22(5):e16443
pubmed: 32348254
Front Psychol. 2018 Nov 23;9:2265
pubmed: 30532720
Front Psychol. 2019 Feb 04;10:158
pubmed: 30778320
J Cardiovasc Electrophysiol. 2020 Jul;31(7):1579-1584
pubmed: 32400079
J Med Internet Res. 2020 Dec 11;22(12):e22703
pubmed: 33259324
Circulation. 2019 Nov 26;140(22):1779-1788
pubmed: 31630538
Clin Cardiol. 2020 Sep;43(9):1032-1039
pubmed: 32700414
Int J Cardiol Heart Vasc. 2019 Jul 27;24:100405
pubmed: 31388561
Am J Cardiol. 2018 Sep 15;122(6):1095-1097
pubmed: 30072130
J Med Internet Res. 2021 Feb 10;23(2):e25499
pubmed: 33565986
Trials. 2019 Dec 27;20(1):782
pubmed: 31882015